BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38114938)

  • 1. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors.
    Jiao T; Tang H; Zhang W; Hu B; Wan T; Cao Y; Zhang Z; Wang Y; Cao J; Cui M; Lu S
    BMC Surg; 2023 Dec; 23(1):384. PubMed ID: 38114938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Hepatectomy for Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus.
    Komatsu S; Kido M; Kuramitsu K; Tsugawa D; Gon H; Fukushima K; Urade T; Yanagimoto H; Toyama H; Fukumoto T
    J Gastrointest Surg; 2022 Apr; 26(4):822-830. PubMed ID: 34716534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
    Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
    Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
    Komatsu S; Ueshima K; Kido M; Kuramitsu K; Tsugawa D; Yanagimoto H; Toyama H; Ku Y; Kudo M; Fukumoto T
    J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):303-314. PubMed ID: 36047804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
    Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy.
    Kim SH; Moon DB; Park YH; Lee SG; Kim KH; Hwang S; Ahn CS; Ha TY; Song GW; Jung DH; Park GC; Kim M; Na BG; Yang G; Kim SM; Oh RK
    Ann Surg Oncol; 2023 Jul; 30(7):4279-4289. PubMed ID: 37043034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
    Hidaka Y; Tomita M; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
    World J Surg Oncol; 2022 Jul; 20(1):228. PubMed ID: 35831894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.
    Fukumoto T; Kido M; Takebe A; Tanaka M; Kinoshita H; Kuramitsu K; Komatsu S; Tsugawa D; Goto T; Asari S; Toyama H; Ajiki T; Ku Y
    Surg Today; 2017 Sep; 47(9):1094-1103. PubMed ID: 28324163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between laparoscopic liver resection and open liver resection in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
    Kim KS; Choi GS; Rhu J; Kim J
    Surg Endosc; 2024 Apr; 38(4):2116-2123. PubMed ID: 38438678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification.
    Xu JF; Liu XY; Wang S; Wen HX
    World J Surg Oncol; 2015 Feb; 13():86. PubMed ID: 25889711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein.
    Ban D; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T
    J Gastrointest Surg; 2009 Nov; 13(11):1921-8. PubMed ID: 19727969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study.
    Tarantino L; Busto G; Nasto A; Fristachi R; Cacace L; Talamo M; Accardo C; Bortone S; Gallo P; Tarantino P; Nasto RA; Di Minno MN; Ambrosino P
    World J Gastroenterol; 2017 Feb; 23(5):906-918. PubMed ID: 28223736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
    Tao ZW; Cheng BQ; Zhou T; Gao YJ
    Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu Y; Li Y; Wang X; Huang Y; Zhang Q; Shi K; Ran C; Hou J; Wang X
    J Altern Complement Med; 2020 Oct; 26(10):956-965. PubMed ID: 32614605
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
    Cao Y; Tang H; Hu B; Zhang W; Wan T; Han J; Jiao T; Li J; Li X; Yang Z; Liu Z; Hu M; Duan W; Li C; Zhao Z; Lu S
    HPB (Oxford); 2023 Jul; 25(7):775-787. PubMed ID: 36973160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
    Li S; Li L; Li B; Wang W
    Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features.
    Zou X; Xu Q; You R; Yin G
    Cancer Med; 2023 May; 12(10):11315-11333. PubMed ID: 36951443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.